Upifitamab, CAS 2254118-43-7

Product Description: Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Richardson D, et al. Updated Results from the Phase 1 Expansion Study of Upifitamab Rilsodotin (UpRi; XMT-1536), a NaPi2b-directed Dolaflexin Antibody Drug Conjugate (ADC) in Ovarian Cancer (076). Gynecologic Oncology, 2022, 166: S48.

CAS Number: 2254118-43-7

Molecular Weight: N/A

Compound Purity: 98.77

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody

• Artikelnummer: MEXHY-P99229-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99229-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK